NEW YORK--(BUSINESS WIRE)--Jan. 20, 2006--Xenomics, Inc. (OTCBB:XNOM) (FWB:XE7), a developer of next-generation medical DNA technologies, today announced that veteran financial executive, Frederick Larcombe, has joined the Company’s management team as Chief Financial Officer. Mr. Larcombe, a financial executive and a Certified Public Accountant for more than 25 years, brings to Xenomics a strong background in finance and strategic planning, with particular expertise in the biotechnology industry. Recent experience includes service as CFO and Vice President of Finance at MicroDose Technologies, a drug-delivery technology developer. He also served as Director of Commercial Development at Cambrex Corp., a life sciences company supporting the discovery and commercialization of therapeutics with more than $400,000,000 in annual revenues, where he helped direct a series of successful acquisitions.
